V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

BACKGROUND: Anemia is common among end-stage renal disease (ESRD) patients who undergone hemodialysis. The total reduction of red blood cell (RBC) count is associated with poor prognosis in these patients. Although erythropoietin (EPO) has been used as an effective treatment for ESRD patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Henry Sung-Ching, Chang, Che-Mai, Kao, Chih-Chin, Hsu, Yu-Wen, Liu, Xiao, Chang, Wen-Chang, Wu, Mai-Szu, Chang, Wei-Chiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504791/
https://www.ncbi.nlm.nih.gov/pubmed/28697735
http://dx.doi.org/10.1186/s12929-017-0349-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504791/
https://www.ncbi.nlm.nih.gov/pubmed/28697735
http://dx.doi.org/10.1186/s12929-017-0349-5

Ejemplares similares